Citation 76515

BLOOR,SJ: QI,L:. (1994). CYTOTOXIC SAPONINS FROM NEW ZEALAND MYRSINE SPECIES.. 57(10)

Citation Details

Title	CYTOTOXIC SAPONINS FROM NEW ZEALAND MYRSINE SPECIES.
Authors	BLOOR,SJ: QI,L:
Year	1994
Volume	57
Issue	10

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (2)

Myrsine australis (MYRSINACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEANANE,3-BETA-O-(BETA-D-XYLOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY-13-BETA-28-EPOXY:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OLEANANE,3-BETA-O-(BETA-D-XYLOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY-13-BETA-28-EPOXY:	ACTIVE
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEANANE,3-BETA-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY-13-BETA-28-EPOXY:	None
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-28-13-BETA-OLIDE,3-BETA-O-(BETA-D-XYLOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY:	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OLEANANE,3-BETA-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY-13-BETA-28-EPOXY:	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OLEAN-28-13-BETA-OLIDE,3-BETA-O-(BETA-D-XYLOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY:	WEAK ACTIVITY
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-28-13-BETA-OLIDE,3-BETA-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY:	None
8	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEANANE,3-BETA-O-(BETA-D-XYLOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-28-DIHYDROXY-13-BETA-28-EPOXY:	None
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OLEAN-28-13-BETA-OLIDE,3-BETA-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-HYDROXY:	WEAK ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OLEANANE,3-BETA-O-(BETA-D-XYLOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-28-DIHYDROXY-13-BETA-28-EPOXY:	WEAK ACTIVITY
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEANANE,3-BETA-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-28-DIHYDROXY-13-BETA-28-EPOXY:	None
12	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ARDISIACRISPIN A	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OLEANANE,3-BETA-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-(O-BETA-D-GLUCOPYRANOSYL(1-2))-ALPHA-L-ARABINOPYRANOSYL)-16-ALPHA-28-DIHYDROXY-13-BETA-28-EPOXY:	WEAK ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARDISIACRISPIN A	ACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ARDISIACRISPIN B	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARDISIACRISPIN B	WEAK ACTIVITY

Myrsine salicina (MYRSINACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARDISIACRISPIN A	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARDISIACRISPIN A	WEAK ACTIVITY
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARDISIACRISPIN A	ACTIVE

Show SPARQL Queries (1)